BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2867735)

  • 1. [Hemodynamics of erection: current pharmacological findings].
    Dorémieux J
    Ann Urol (Paris); 1985; 19(5):327-32. PubMed ID: 2867735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Plea for the use of facilitator drugs. 2. Diagnostic and therapeutic applications].
    Buvat J; Buvat-Herbaut M; Lemaire A; Marcolin G
    J Urol (Paris); 1989; 95(2):89-96. PubMed ID: 2567319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intracavernous injections: role in the diagnosis and therapy of problems in erection].
    Jardin A; Benoit G; Giuliano F
    Journ Annu Diabetol Hotel Dieu; 1993; ():359-74. PubMed ID: 8101244
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drugs for impotence].
    Lukkarinen O; Pelkonen R
    Duodecim; 1995; 111(8):771-6. PubMed ID: 8681837
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
    Mzo EB; Dmitriev DG
    Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection.
    Kadioğlu A; Memişoğlu K; Sazoya O; Tüzün E
    Arch Esp Urol; 1998 Sep; 51(7):739-40. PubMed ID: 9807905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erection induced by papaverine].
    Török A; Székely J; Götz F
    Orv Hetil; 1988 Nov; 129(45):2401-3. PubMed ID: 3186244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of electromyography of the corpora cavernosa (single potential analysis of cavernous electric activity--SPACE) as a technique for studying impotence].
    Salinas Casado J; Vírseda Chamorro M; Samblas García R; Esteban Fuertes M; Aristizábal Agudelo JM; Blázquez Izquierdo J; Delgado Martín JA; Resel Estévez L
    Arch Esp Urol; 1997 Jun; 50(5):512-9. PubMed ID: 9382594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence.
    de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of treatment of erectile disorders by the administration of vasoactive substances into the penis using iontophoresis].
    Babula V; Sedmík J; Zvĕrina J
    Cas Lek Cesk; 1989 Oct; 128(43-44):1367-8. PubMed ID: 2598251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penile extensibility and erectile function. Preliminary results].
    Bondil P; Louis JF; Daures JP; Costa P; Navratil H
    Ann Urol (Paris); 1990; 24(5):373-7. PubMed ID: 2252345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
    Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
    Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically induced penile erections in the assessment and treatment of erectile impotence: a preliminary study of 100 patients.
    Goonawardena SA; de Silva WA; Ketheeswaran T
    Ceylon Med J; 1997 Jun; 42(2):72-4. PubMed ID: 9257465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases].
    Bondil P; Rigot JM; Nguyen Qui JL; Mazeman E
    J Urol (Paris); 1987; 93(9-10):547-8. PubMed ID: 3443767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.